<code id='AB777F115D'></code><style id='AB777F115D'></style>
    • <acronym id='AB777F115D'></acronym>
      <center id='AB777F115D'><center id='AB777F115D'><tfoot id='AB777F115D'></tfoot></center><abbr id='AB777F115D'><dir id='AB777F115D'><tfoot id='AB777F115D'></tfoot><noframes id='AB777F115D'>

    • <optgroup id='AB777F115D'><strike id='AB777F115D'><sup id='AB777F115D'></sup></strike><code id='AB777F115D'></code></optgroup>
        1. <b id='AB777F115D'><label id='AB777F115D'><select id='AB777F115D'><dt id='AB777F115D'><span id='AB777F115D'></span></dt></select></label></b><u id='AB777F115D'></u>
          <i id='AB777F115D'><strike id='AB777F115D'><tt id='AB777F115D'><pre id='AB777F115D'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:9641
          Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT
          Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

          The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

          advertisement

          Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play

          DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          What to expect at HLTH 2023, the health care industry conference

          AdobeSTAT’sMohanaRavindranathandAnnalisaMerelliwillbeatHLTHinLasVegasandwillbewritingadailyemaildisp